Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 12-2024 | 09-2024 | |
| Sales | 0 | 216,833 | 181,398 | 0 | 101,620 |
| Cost of Goods | N/A | 69,327 | 67,713 | N/A | 57,208 |
| Gross Profit | N/A | 147,506 | 113,685 | N/A | 44,412 |
| Operating Expenses | 0 | 115,191 | 132,387 | 0 | 105,462 |
| Operating Income | N/A | 32,642 | -17,989 | N/A | -60,842 |
| Interest Expense | 0 | 13,507 | 19,208 | 0 | 13,799 |
| Other Income | 0 | 5,190 | -34,593 | 0 | 6,912 |
| Pre-tax Income | 0 | 24,325 | -71,790 | 0 | -67,729 |
| Net Income Continuous | N/A | 24,325 | -71,790 | N/A | -67,729 |
| Net Income | $N/A | $24,325 | $-71,790 | $N/A | $-67,729 |
| EPS Basic Total Ops | N/A | 0.09 | -7.97 | N/A | -2.59 |
| EPS Basic Continuous Ops | N/A | 0.09 | -1.11 | N/A | -1.90 |
| EPS Diluted Total Ops | N/A | 0.08 | -7.97 | N/A | -2.59 |
| EPS Diluted Continuous Ops | N/A | 0.08 | -1.11 | N/A | -1.90 |
| EPS Diluted Before Non-Recurring Items | 0.28 | 0.08 | -0.54 | N/A | N/A |
| EBITDA(a) | $N/A | $39,975 | $-17,989 | $N/A | $-48,484 |